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Abstract
Background: Osteoporosis treatment guidelines recommend calcium and vitamin D supplementation for both
prevention as well as treatment, however, compliance with these guidelines is often unsatisfactory. This study
investigated the opinion of Asian physicians and Asian patients regarding vitamin D and calcium and patients’ use
of both.
Methods: Physicians selected from Malaysia, Taiwan, Philippines, Korea and Singapore were asked to grade the
significance of vitamin D and calcium in the treatment of osteoporosis and their patients’ use of these
supplements. In addition, physicians recruited seven eligible osteoporotic women to answer a questionnaire to
determine their use of vitamin D and calcium, and their attitudes and beliefs regarding these supplements.
Results: In total, 237 physicians and 1463 osteoporosis patients completed the questionnaire. The results revealed
that 22% of physicians in Malaysia, 12% in Taiwan, 72% in the Philippines, 50% in Korea and 24% in Singapore
rated the importance of vitamin D supplementation as being extremely important. For calcium, 27% of physicians
in Malaysia, 30% in Taiwan, 80% in the Philippines, 50% in Korea and 38% in Singapore rated the importance as
being extremely important. Forty-three percent of patients in Malaysia, 38% in Taiwan, 73% in the Philippines, 35%
in Korea and 39% in Singapore rated the importance of vitamin D as being extremely important. For calcium, 69%
of patients in Malaysia, 58% in Taiwan, 90% in the Philippines, 70% in Korea and 55% in Singapore rated the
importance as being extremely important. In addition, results of the patient questionnaire revealed that only a very
small number regularly took both supplements. In addition, the results indicated that, with the exception of
patients from the Philippines, the majority of patients had no or infrequent discussion with their physician about
vitamin D and calcium.
Conclusions: There is generally suboptimal appreciation by both physicians and patients of the importance of
vitamin D and calcium for maintenance of bone health as reflected in the low number of patients who reported
regularly taking these supplements. Recognition of this problem should translate to appropriate action to improve
education for both physicians and patients, with a goal to increase use of these supplements among Asian
patients with osteoporosis.
Background
The effect of osteoporosis on public health and the
resultant financial burden are considerable [1,2]. Until
recently the majority of epidemiological studies on
osteoporosis have been performed in Western Caucasian
populations in which the incidence of osteoporosis is
high [2]; but as Asian populations become more aged,
similar phenomena are being observed with the inci-
dence of osteoporosis increasing [3-5]. Hip fracture is a
significant public health problem today in Asia as in
Europe and North America. It has been projected that
by the year 2050, 50% of hip fractures worldwide will
occur in Asia [6-8]. Although the incidence of hip frac-
ture is generally lower in Asia [9], there is variation in
the rate based on ethnicity and geographic location
[5,10]. The underlying mortality rate and functional
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Caucasian populations [10-13]. Compounding the pro-
blem of increased incidence of osteoporosis in Asian
populations is the findings from epidemiological studies
that have identified a high incidence of vitamin D inade-
quacy[14,15]. Vitamin D deficiency has also been identi-
fied in postmenopausal women in Eastern Asia [16].
Effective therapies are now available for the treatment
of osteoporosis, most notably the oral bisphosphonates,
currently the most commonly used therapeutic modality
for this disease [17]. In addition to the various active
anti-osteoporosis agents, there is clear evidence that ade-
quate vitamin D and calcium intake also play significant
roles in ameliorating the severity of osteoporosis and are
necessary for optimal response to pharmacologic inter-
vention [18,19]. Vitamin D and calcium can be obtained
directly via the diet or by supplementation [20,21]. A
chronically low intake of calcium in the diet decreases
bone mass and leads to an increased risk of osteoporosis
and bone fracture [22]. Calcium supplementation alone
has been demonstrated to increase bone mineral density
and to decrease the rate of fracture in postmenopausal
women [23-27]. Likewise, addition of supplemental vita-
min D to the diet has also been shown to reduce fracture
rate in postmenopausal women [28,29]. Combination of
both calcium and vitamin D supplementation has been
shown to reduce the rate of bone mineral density loss
and fracture rates [30-33]. Consequently, most clinical
guidelines recommend supplementation with calcium
and vitamin D to optimize the efficacy of pharmacologic
therapies for osteoporosis [20,34].
Guidelines regarding the recommended daily calcium
intake vary according to gender, life stage, and also from
region to region [35,36]. However, the present recom-
mended minimum daily calcium intake for adults ranges
from 1000-1300 mg [35-37]. Even though calcium is rela-
tively common [35,38] in the diet, supplementation is fre-
quently necessary. Intake is often insufficient due to
religious or dietary restrictions, lactose intolerance, etc. It
is recommended that if dietary intake of calcium-rich
foods is inadequate, supplements containing elemental
calcium (calcium citrate and calcium carbonate) should
be taken [35]. It should be noted that commonly used
multivitamin supplements often do not contain sufficient
calcium to make up for deficiency in the diet [35].
Increasing calcium intake alone is insufficient for ade-
quate maintenance of bone mass. Sufficient vitamin D is
required for optimal intestinal calcium absorption [39].
Calcium absorption decreases as 25-hydroxyvitamin D
(25(OH)D) levels decrease, leading to bone loss [40]. As a
result, persistently low levels of vitamin D are linked to
reduced bone density and an increase in the risk of fragi-
lity fracture [41]. At present, the US National Institutes
of Health Institute of Medicine recommends a daily
intake of 400 IU of cholecalciferol (vitamin D3)f o r
women ages 51-70 years, increasing to 600 IU for women
over age 70 [36]. The Scientific Committee for Food of
the Commission of the European Community presently
recommends 400 IU daily for those 65 years of age or
older [42]. Despite the recommendations of these bodies,
many women being treated for osteoporosis do not regu-
larly take sufficient vitamin D supplementation and have
low serum 25(OH)D levels, the clinical parameter used to
measure vitamin D status [29,43]. Unlike calcium, which
is readily available in a number of dietary sources, dietary
sources of vitamin D are more restricted (oily fish, some
fortified foods, and egg yolks). Apart from these limited
dietary sources of vitamin D, the alternative source is
exposure to sunlight. However, exposure to sunlight is
often limited for adequate synthesis due to lack of sun-
light in Northerly latitudes or due to the avoidance of
exposure for cosmetic/cultural reasons and concerns
about the risk of skin cancer. As a result, most people are
likely to require supplementation to be vitamin D replete
[44-46]. Although vitamin D is necessary for regulation
of calcium metabolism and maintenance of normal bone
health, a significant body of evidence indicates that vita-
min D deficiency/inadequacy is common [47,48]. Nota-
bly, low levels of vitamin D are frequently observed in
older females, the population most affected by osteoporo-
sis [49-51]. Despite the clear evidence for vitamin D
inadequacy playing an important role in aggravating
osteoporosis, this involvement is not widely understood,
recognized or appreciated by physicians as well as
patients [39,45,52,53].
A recent study, Incidence and Characterization of
inadequate clinical Responders in Osteoporosis
(ICARO), observed that lack of compliance with treat-
ment and insufficient supplementation of calcium and
vitamin D have a major impact on response to therapy
in osteoporosis [54]. It has been reported in a recently
conducted questionnaire that while patients are knowl-
edgeable about the role of calcium as a bone-building
agent, but they are less knowledgeable about the role of
vitamin D in this process [55]. This study and others
have highlighted the lack of compliance among patients
who were aware of the importance of both vitamin D
and calcium [34]. Although a number of European stu-
dies have described differences in attitudes and beliefs
between physicians and their patients on matters regard-
ing osteoporosis, current therapies, and compliance
[56,57], few have explored these issues in Asian popula-
tions. The goal of this study was to measure physicians’
and patients’ attitudes and beliefs regarding vitamin D
and calcium and their importance in the treatment of
osteoporosis and to detail perception and actual compli-
ance with guidelines regarding these supplements in
Asian populations.
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Questionnaire design
Throughout 2006, a total of 237 randomly selected phy-
sicians in Malaysia (n = 37), Taiwan (n = 50), the Philip-
p i n e s( n=5 0 ) ,K o r e a( n=5 0 )a n dS i n g a p o r e( n=5 0 )
were requested to enroll seven consecutive eligible
osteoporosis patients who were willing to take part in a
telephone questionnaire concerning the significance of
vitamin D and calcium to osteoporosis therapy. As it
can be complex to enroll physicians to answer a ques-
tionnaire of this nature, a sample of 50 physicians per
country was considered to be a reasonable minimum
number to acquire results with a good degree of statisti-
cal robustness. The physicians were requested to enroll
the first seven osteoporosis patients who met the inclu-
sion criteria. This was thought to be an acceptable
undertaking for the physicians and would provide the
opportunity to analyze patient results by sub-groups.
This method was used to help randomize the mix of
subjects enrolled, hence ensuring that the participating
subjects were nationally representative for the enroll-
ment criteria. Statistical power was not provided by the
physician or patient sample sizes, and these population
sizes were used by the questionnaire designers’ previous
k n o w l e d g eo fw h a ts a m p l es i z e sa r ea c h i e v a b l ea n dr e a -
sonable, given the goals and budget of the study. Physi-
cians included such specialties as General Medicine,
Internal Medicine, Gynecology, Orthopedic Surgery,
Geriatrics, and Rheumatology, specialties that are most
likely to treat patients with osteoporosis.
A convenient sample of physicians was chosen from
physician licensure databases from each country partici-
pating in the study. Only post-menopausal women ≥ 50
years of age who had been diagnosed with and were
being treated for osteoporosis were eligible to partici-
pate. Exclusion criteria for both physicians and patients
included participation in any market research involving
women’s health during the 3-months prior to participat-
ing in the questionnaire and/or having a relative who is
employed by a pharmaceutical company.
The questionnaire was translated to the local language
and validated in the countries that the study was under-
t a k e n .T h eq u e s t i o n n a i r ew a sc o n d u c t e db yas k i l l e d
local contractor.
This survey was conducted in accordance with the
Declaration of Helsinki guidelines for good clinical prac-
tice. Patients were informed about the survey by their
physician and voluntarily contacted the survey adminis-
trators to participate. Patients were instructed about the
nature of the survey and gave their consent to partici-
pate. Since participation did not affect patient care,
Institutional Review Board and ethics committee review
was not required. Physician and patient response data
were collected, managed, and secured by Research
International Healthcare, which has defined procedures
to maintain the security and confidentiality of the data.
It was determined that General practitioners should see
a minimum of 10 patients with osteoporosis each month,
whereas specialists were required to see a minimum of 15
osteoporosis patients each month. However, it should be
noted that these enrollment criteria were ascertained by
self reporting, and no further validation was performed.
To make certain of an adequate level of experience, physi-
cians were required to have been in practice for ≥ 3 years
or < 30 years, to guarantee a good level of experience, and
to be current with recent treatment practices. Physicians’
participation in the questionnaire occurred after complete
enrollment of the minimum seven suitable patients and
only once those patient questionnaires were finalized in
order to minimize the risk that physicians might inadver-
tently or purposefully influence patient answers. Nonethe-
less, it is possible that patients may have obtained some
knowledge of the subject matter from the physician at the
time of their enrollment. Physicians had no knowledge of
the precise nature of the patient questionnaires or aims of
the study prior to the patient interviews; hence it would
have been unlikely that physicians could influence patient
responses even if desired. However, the authors concede
that they cannot guarantee that previous interactions
between patient and physician prior to interviewing of
either party did not impact responses. During the course
of the study, however, a number of physicians did not
enroll the required 7 patients, and consequently the
patient number criterion (400 per country) was relaxed so
that the study could be concluded. The final number of
completed patient questionnaires was as follows: Malaysia
(n = 251), Taiwan (n = 218), the Philippines (n = 194),
Korea (n = 400) and Singapore (n = 400).
The protocol for the questionnaire involved the use of
telephone interviews for both physicians and patients
using a 16-question questionnaire. The questionnaire for
both patient (Additional file 1) and physician (Addi-
tional file 2) involved the use of open-ended response
items, closed-end questions, and scale items (scale from
1-10, where 1 = not important at all, and 10 = extremely
important).
Some of the major questions that this questionnaire
was intended to answer were:
1. Are physicians and patients knowledgeable regard-
ing the importance of vitamin D and calcium in the
management of osteoporosis?
2 .A r eo s t e o p o r o s i sp a t i e n t sc o m p l i a n tw i t ht h e i r
recommended dosing regimens for supplementary
vitamin D and calcium?
3. Are physicians aware of their osteoporosis
patients’ willingness to follow recommended dosing
regimens for supplementary vitamin D and calcium?
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regarding the need for vitamin D and calcium in the
treatment of osteoporosis?
To ensure that the data collected was valid, quality
checks were performed to ensure that answers complied
with the basic rules of the questionnaire such as no
multi-response answers for single-response questions.
Although data were not checked to ensure that the sub-
jects responded reliably to all questions, there are no
grounds to assume that subjects did not respond to the
best of their knowledge and ability. The questionnaires
were designed to collect demographic data and obtain
answers regarding the subjects’ attitudes and beliefs in
regards to vitamin D and calcium in the treatment of
osteoporosis.
Statistical/data analysis
Statistical analysis was performed utilizing a Microsoft
Excel-based analysis tool. A standard two-tailed tests set
at p < 0.01 (99% level of significance) were employed to
test data between countries. We determined whether
percentages or mean scores were appropriate. In the
case of ordinal scales, statistical analyses were performed
on differences between percentages for individual
answer options, rather than on differences between
means. Differences were often performed between per-
centages rather than means as certain scales are not lin-
ear and hence a mean score is irrelevant. Analyses were
only performed between countries.
Results
Physician and patient characteristics
Two hundred and thirty seven physicians participated:
37 from Malaysia, and 50 each from Taiwan, the Philip-
pines, Korea and Singapore; demographics are shown in
Table-1. 1463 osteoporosis patients (251, 218, 194, 400
and 400 from Malaysia, Taiwan, the Philippines, Korea
and Singapore respectively) participated in the question-
naire; demographic data are shown in Table 2.
Although each physician was requested to enroll a
minimum of seven patients, the enrollment target was
not met in Malaysia, Taiwan and the Philippines. Conse-
quently numbers required to achieve statistically signifi-
cant differences in attitude and belief between Malaysia,
Taiwan and the Philippines and other countries is
slightly higher than it would have been if enrollment
targets had been met. For example if 50% of patients in
Korea (n = 400) replied ‘yes’ to a question, whereas 60%
replied ‘yes’ in Singapore (n = 400) and Taiwan (n =
218), Korea and Singapore would differ at a level of 99%
confidence whereas Korea and Taiwan would not
(though they would at a level of at least 95%). The phy-
sicians were on average 45.5 years old and had been
practicing for a mean of 14.8 years. There were no sta-
tistically significant differences between countries with
respect to mean physician age or mean practice experi-
ence. Most were general practitioners or orthopedists.
Mean patient age was 63.4 years, and mean length of
time since osteoporosis diagnosis was 2.6 years. There
were no statistically significant differences between
countries with respect to mean patient age or mean
length of time since osteoporosis diagnosis.
Physician and patient awareness of the importance of
vitamin D and calcium in the management of
osteoporosis
In response to the question on the importance of vita-
min D and calcium in management of osteoporosis,
using a scale of 1 to 10 (where 1 = not important at all;
and 10 = extremely important), vitamin D was thought
to be of high importance (>8) in the management of
osteoporosis by 72% of physicians in the Philippines
compared with 22% in Malaysia, 12% in Taiwan, 50% in
Korea and 24% in Singapore (Figure 1). Calcium was
also thought to be of high importance (>8) in the man-
agement of osteoporosis by 80% of physicians in the
Philippines compared with 27% in Malaysia, 12% in Tai-
wan, 50% in Korea and 38% in Singapore (Figure 1).
Within each country, with the exception of Korea, phy-
sicians gave more importance to calcium than to vita-
min D.
In response to the same question regarding the impor-
tance of vitamin D and calcium in the management of
osteoporosis, patients, like physicians, generally consid-
ered calcium to be more important than vitamin D (Fig-
ure 2). Vitamin D was thought to be of high importance
(>8) in the management of osteoporosis by 73% of
patients in the Philippines compared with 43% in Malay-
sia, 38% in Taiwan, 35% in Korea and 39% in Singapore
(Figure 2). Calcium was thought to be of high impor-
tance (>8) in the management of osteoporosis by 90% of
patients in the Philippines compared with 69% in Malay-
sia, 58% in Taiwan, 70% in Korea and 55% in Singapore
Compliance with of calcium and vitamin D supplements
and physician and patient discussion regarding
supplements
Malaysia
In Malaysia, only 13% of patients reported taking both
calcium and vitamin D supplements either separately
(6%) or together in a combination pill (7%) (Figure-3).
However, 83% of those patients who take supplements
reported taking supplements recommended by their
doctor daily, while 3% reported taking supplements
most days (Figure 4). Fifty-one percent of physicians
estimated that their patients were fully compliant and
took their supplements, which included vitamin D, daily,
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84% and 51% of the patients reported that their physi-
cian never discussed the importance of vitamin D and
calcium, respectively, in relation to the management of
their osteoporosis (Figure 6a and 6b).
Taiwan
Thirty percent of patients in Taiwan reported taking
both calcium and vitamin D supplements either sepa-
rately (8%) or together in a combination pill (22%) (Fig-
ure 3), and of those, 91% took the supplements on a
regular basis (83% every day; 9% most days) (Figure 4).
Eighteen percent of physicians estimated that their
patients were fully compliant and took their supple-
ments daily, while 16% estimated compliance on most
days (Figure 5). The majority of patients in Taiwan
(75%) reported that they had had no (46%) or infrequent
(29%) discussions with their physicians about vitamin D,
and almost 50% of patients reported, no (16%) or infre-
quent (33%) discussions with their physicians about cal-
cium (Figure 6a and 6b).
Table 1 Physicians demographics
Demographics-physicians Malaysia
(n = 37)
Taiwan
(n = 50)
Philippines
(n = 50)
Korea
(n = 50)
Singapore
(n = 50)
% Actual % Actual % Actual % Actual % Actual
Medical speciality GP/IM (Internist) 59 22 14 7 - - 30 15 50 25
Gynecologist 11 4 2 1 20 10 12 6 4 2
Orthopedist 1 6 6 6 03 03 81 95 42 73 01 5
Geriatrician 8 3 18 9 20 10 - - 4 2
Rheumatologist 52631 054284
Endocrinologist --------42
Other ---- 1 2 6----
Years in practice following medical school 4-10 1 6 6 3 61 84 82 43 81 92 41 2
11-15 22 8 28 14 14 7 26 13 24 12
16-20 5 2 20 10 18 9 16 8 22 11
21-25 27 10 12 6 16 8 14 7 22 11
26-30 3 0 1 1 42426384
30-45 38 14 60 30 58 29 54 27 62 31
Age 46-55 41 15 40 20 22 11 38 19 32 16
56-65 2 2 8--2 0 1 08463
Location Urban -- 8 8 4 4 ------
Rural -- 1 2 6------
Table 2 Patient demographics
Demographics-patients Malaysia
(n = 251)
Taiwan
(n = 218)
Philippines
(n = 194)
Korea
(n = 400)
Singapore
(n = 400)
% Actual % Actual % Actual % Actual % Actual
In past year 35 89 28 62 56 109 80 320 35 139
Length of time since diagnosis Last 5 years 49 123 47 103 37 71 16 64 50 198
6-10 years 11 28 18 39 5 10 4 14 12 47
11-15 years 264911124 1 4
16-20 years 121211---1
21+ years 131322---1
Taking vitamins or minerals to help treat osteoporosis Yes 67 167 88 191 87 168 62 249 86 343
No 33 84 12 27 13 23 38 151 14 57
50-54 24 59 34 74 11 22 10 40 27 106
55-59 22 54 17 37 16 32 14 55 23 91
Age 60-64 17 42 19 41 21 40 21 84 15 59
65-69 13 33 10 22 15 30 19 76 15 60
70-74 12 30 10 22 12 23 19 77 12 49
75+ 13 33 10 22 24 47 17 68 9 35
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In the Philippines, 55% of patients reported taking both
calcium and vitamin D supplements either separately
(45%) or together in a combination pill (10%) (Figure 3),
with 98% taking supplements on a regular basis (93%
every day; 5% most days) (Figure 4). Eighty-four percent
of physicians estimated that their patients were fully
compliant and took their supplements daily, while 6%
estimated compliance on most days (Figure 5). Less
than half of the patients reported that they had had no
(16%) or infrequent (25%) discussions with their physi-
cians regarding vitamin D, while 3% reported no and
16% reported infrequent discussions about calcium (Fig-
ure 6a and 6b).
Korea
In Korea, 23% of patients reported taking both calcium
and vitamin D supplements either separately (9%) or
together in a combination pill (14%) (Figure 3), with 81%
taking supplements on a regular basis (73% every day; 8%
on most days) (Figure 4). Physicians reported that only
14% of their patients take their supplements daily and
12% take their supplements most days (Figure 5). The
majority of patients in Korea (75%) reported that they
had had no (55%) or infrequent (24%) discussions with
their physicians about vitamin D and 51% of patients
reported, no (17%) or infrequent (34%) discussions with
their physicians about calcium (Figure-6a and 6b)
Singapore
In Singapore, 69% of patients reported taking both cal-
cium and vitamin D supplements either separately (46%)
or together in a combination pill (23%) (Figure 3), with
91% of those doing so on a regular basis (76% every day;
15% on most days) (Figure 4). Physicians reported that
42% of their patients take their supplements daily, while
50% take their supplements on most days (Figure 5).
The majority of patients in Singapore (86%) reported
that they had had no (55%) or infrequent (31%) discus-
sions with their physicians regarding vitamin D, and
76% of patients reported, no (40%) or infrequent (36%)
discussions with their physicians about calcium (Figure
6a and 6b).
Discussion
Supplementation of dietary calcium and vitamin D plays
a critical role in the therapy of osteoporosis [20,53].
Given the essential role of vitamin D in calcium
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negatively impacts calcium metabolism irrespective of
intake of sufficient dietary or supplemental calcium
[40,45]. Therefore insufficient and sporadic intake of
vitamin D can lead to chronic vitamin D deficiency/
insufficiency, thereby reducing the effectiveness of
osteoporosis treatment [40,45].
The outcome of this study has demonstrated that phy-
sicians in Malaysia, Taiwan and Singapore had a poor
appreciation of the importance of vitamin D and cal-
cium for bone health, physicians in Korea had a fair
appreciation of it and physicians in the Philippines had
a heightened appreciation of the importance of both for
bone health. In general, there was a good understanding
of the importance of vitamin D and calcium among
patients from these five countries, although it was evi-
dent that patients considered calcium to be more
important than vitamin D.
Given the poor understanding among physicians and
patients that vitamin D is central to maintenance of
bone health; it is not surprising that the percentage of
patients who frequently took vitamin D supplements
was low. In Malaysia, Taiwan and Korea, less than 30%
of patients reported taking vitamin D and calcium.
Although the questionnaire highlighted, with the
exception of the Philippines, a poor awareness among
physicians of the importance of calcium and, in particu-
lar, vitamin D in osteoporosis management, this resulted
in poor advice for patients, as at least 50% of patients in
Malaysia, Taiwan, Korea, and Singapore reported no or
infrequent discussions with their physicians regarding the
importance of vitamin D and calcium supplementation.
Of these five countries, the Philippines clearly stood out
as the country where both physicians and patients under-
stood the importance of both vitamin D and calcium in
the management of osteoporosis. This understanding
resulted in a high compliance among patients for supple-
ments to be taken with osteoporosis treatments.
This study provides additional evidence that in Asian
countries compliance with treatment guidelines is not
optimal among osteoporosis patients that may be at
high risk for vitamin D insufficiency/deficiency [58-60].
The prevalence of vitamin D insufficiency is high in
South Asian countries [14,16] and although it is highly
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min D supplementation is the sole cause, it is possible
that this may be a contributory factor.
In accordance with a number of other studies, this
study clearly demonstrates that physicians generally mis-
judge their patients’ compliance with their osteoporosis
treatment and their readiness to adhere to treatment
directions. The largest discrepancies between physician
estimates and patient-reported compliance were in Tai-
wan and Korea, where 83% and 73% of patients who
take supplements, respectively, state that they take them
every day, whereas only 18% of physicians in Taiwan
and 14% in Korea estimated their patients were fully
compliant. In Malaysia these figures were 83% of
patients vs. 51% of physicians; in Singapore 76% of
patients vs. 42% of physicians. The exception was in the
Philippines, where 93% of patients and 84% of physi-
cians reported compliance.
It is possible that this effect is because physicians are
hesitant to state that their patients take their vitamin D
and calcium supplements every day. By combining the
responses for compliance most days with compliance
every day, then the results are more similar (86% of
patients vs. 78% of physicians in Malaysia; 98% vs. 90%
in the Philippines; 91% vs. 92% in Singapore); however,
even after combining these responses, the difference
between patient- and physician-reported compliance in
Taiwan and Korea was significant.
Responses to the questionnaire by patients about how
the frequently their physicians discussed vitamin D and
calcium with them revealed that, in each case, half of
the patients reported that fewer discussions occurred
than their physicians reported (data not shown). Inter-
estingly, results from the Philippines demonstrated the
greatest agreement between patient and physicians of all
the countries studied in the region. In addition, patients
in the Philippines not only reported discussions with
physicians at a frequency similar to that reported by the
physicians themselves, the patients also reported the
occurrence of discussions about vitamin D and calcium
at a higher level than the other countries studied. In all
countries studied, patients reported that calcium was
discussed more frequently than vitamin D.
It is generally accepted that patients have improved
health outcomes when they are better informed and are
involved their treatment [61]. The patients’ compliance
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Page 8 of 13with treatment is improved when the reason for treat-
ment is explained in combination with details of the
potential effectiveness of the therapies [61].
The findings from this study advocate that there is a need
to enhance patients’ and physicians’ communication
regarding the importance of vitamin D and calcium supple-
mentation in treating osteoporosis. Evidence supporting
this conclusion can be observed clearly in the study findings
from the Philippines, where there was the best patient-
reported communication from physicians regarding vitamin
D and calcium. This led to an increased understanding of
the importance of vitamin D and calcium in the treatment
of osteoporosis and increased patient compliance for both
supplementary vitamin D and calcium.
Although a lack of information may lead to a lack of
compliance in addition to a lack of understanding, com-
pliance may also be particularly low among elderly
osteoporosis patients [62]. It has been reported that
two-thirds of aged patients with hip fracture who were
recruited into a postsurgical follow-up program had low
levels of vitamin D. Even after consultation explaining
the necessity of calcium and vitamin D supplementation
in osteoporosis therapy, them a j o r i t yo ft h e s ep a t i e n t s
were still not compliant with the recommended guide-
lines 3 months after discharge from hospital
55. A poten-
tial reason for this observation may be declining
compliance as the number of medications increases, and
older patients frequently take several medications to
treat a range of comorbidities [61,63,64]. The average
age of the patients in our study was 63.4 years.
Limitations
The degree to which these results are applicable to the
entire Asian population is unclear. Although the ques-
tionnaire was completed by a relatively large number of
patients and physicians, care must be used when apply-
ing the results to the entire Asian population, since par-
ticipating physicians were chosen from among specific
specialty databases, instead of randomly selected from
the entire physician population in Malaysia, Taiwan, the
Philippines, Korea and Singapore. This study utilized
patients’ self-reporting of their knowledge of, use of and
compliance with vitamin D and calcium. It is frequently
the case that self-reporting of compliance has a ten-
dency to be elevated. Another possible limitation of this
study was the inability to determine baseline beliefs
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Page 9 of 13regarding the severity and/or perceived susceptibility
related to osteoporosis. Despite these possible limita-
tions, the results are in agreement with other reports
[27,46-48] and underscore the importance of improving
the management of osteoporosis by increasing patient
and physician understanding of the importance of vita-
min D and calcium in maintaining bone health.
Conclusions
The effect of therapies for osteoporosis can be maxi-
mized by the addition of supplementary vitamin D and
calcium to the diet. It appears that physicians and
patients, with the notable exception of the Philippines,
lack knowledge of the potential benefits of calcium and
vitamin D supplementation, and consequently, compli-
ance with the dosing regimen was observed to be insuf-
ficient. Although the insidious nature of this disease, the
paucity of immediate perceptible benefit and an inade-
quate patient motivation may be reasons to explain
reduced compliance, this questionnaire underlines the
need to improve the way this information is communi-
cated to patients and physicians, to define more effective
educational and behavioral involvement, and to design
additional studies to identify the underlying reasons for
the disparities between the recognized benefits of sup-
plementary calcium and vitamin D and the low compli-
ance with these by osteoporosis patients.
Additional material
Additional file 1: Osteoporosis patient questionnaire. This file
contains the questionnaire that was used for patients in this study.
Additional file 2: Osteoporosis physician questionnaire. This file
contains the questionnaire that was used for physicians in this study.
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